Research Use Only. This product is intended as a research chemical only. Not for human or animal use.

Weight Loss

Retatrutide

10 mg

>99% HPLC

Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This triple mechanism represents the cutting edge of metabolic research with unprecedented efficacy in preclinical models.

Lab Result

Retatrutide 10mg

Batch 022026

Avg. Purity

99.8%

Avg. Mass

9.89 mg

Result Date

March 10, 2026

Date Added

March 10, 2026

How it Works

In Plain Language

If Tirzepatide (dual agonist) presses two metabolic buttons, Retatrutide presses three. The third button (glucagon receptor) tells the liver to burn more fat for energy and raises body temperature slightly - like turning up the body's thermostat. This triple approach is showing the most dramatic results in metabolic research to date.

Pathway Overview

Administration

Receptor Binding

Pathway Activation

Biological Response

Research Applications

Triple pathway activation

Enhanced thermogenesis

Superior metabolic modulation

Hepatic fat research